Hepatic O-2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost

Citation
K. Trager et al., Hepatic O-2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost, INTEN CAR M, 26(10), 2000, pp. 1531-1539
Citations number
41
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
INTENSIVE CARE MEDICINE
ISSN journal
0342-4642 → ACNP
Volume
26
Issue
10
Year of publication
2000
Pages
1531 - 1539
Database
ISI
SICI code
0342-4642(200010)26:10<1531:HOEALE>2.0.ZU;2-4
Abstract
Objective: To compare the effects of a 12 h continuous infusion of iloprost , a stable prostacyclin analogue, on hepatic blood flow (Q(liv)), O-2 excha nge, and energy metabolism during a 24 h hyperdynamic, porcine endotoxemia with volume resuscitation alone. Design: Prospective, randomized, experimen tal study with repeated measures. Setting: Investigational animal laborator y. Subjects: Twenty-eight domestic pigs: 16 animals during endotoxemia with volume resuscitation alone (ETX), 12 with endotoxemia, volume resuscitatio n, and treatment with iloprost (ILO). Interventions: Endotoxemia was initia ted by continuous infusion of E. coil lipopolysaccharide. Animals were resu scitated with hetastarch, aimed at maintaining a MAP of > 60 mmHg. After 12 h of endotoxemia, iloprost was administered for 12 h in the treatment grou p, titrated to avoid pharmacologically induced hypotension (MAP < 60 mmHg). Measurements and results: Iloprost significantly increased Q(liv), with no effect on hepatic O-2 delivery. Mean capillary hemoglobin O-2 saturation ( HbScO(2)) on the liver surface, as well as HbScO(2) frequency distributions - a measure of microcirculatory O-2 availability - remained unchanged. Tre atment with iloprost, however, significantly attenuated the endotoxin-induc ed derangements of cellular energy metabolism as reflected by the diminishe d progressive decrease in hepatic lactate uptake rate and a blunted increas e in hepatic venous lactate/pyruvate ratios. While endotoxin significantly increased endogenous glucose production (EGP) rate, iloprost restored EGP t o normal at the end of the experiment. Conclusions: Thus, in a clinically r elevant model of human sepsis, iloprost did not produce potential adverse e ffects but rather ameliorated hepatic metabolic disturbances and, thereby, hepatic energy balance.